US BANCORP \DE\ - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,560
-92.0%
361
-87.8%
0.00%
Q2 2023$19,559
+698.0%
2,968
+722.2%
0.00%
Q1 2023$2,451
-33.5%
361
-27.7%
0.00%
Q4 2022$3,688
-26.2%
4990.0%0.00%
Q3 2022$5,000
-70.6%
499
-67.4%
0.00%
Q2 2022$17,000
+41.7%
1,531
+45.7%
0.00%
Q1 2022$12,000
+300.0%
1,051
+407.7%
0.00%
Q4 2021$3,000
-25.0%
2070.0%0.00%
Q3 2021$4,000
-77.8%
207
-75.5%
0.00%
Q2 2021$18,000
+38.5%
8460.0%0.00%
Q1 2021$13,000
+116.7%
846
+89.7%
0.00%
Q4 2020$6,000
-33.3%
446
-51.7%
0.00%
Q3 2020$9,000
-47.1%
924
-39.8%
0.00%
Q2 2020$17,000
-22.7%
1,535
-25.1%
0.00%
Q1 2020$22,000
-58.5%
2,049
-37.2%
0.00%
Q4 2019$53,000
-39.8%
3,262
-50.8%
0.00%
Q3 2019$88,000
-76.3%
6,626
-74.9%
0.00%
-100.0%
Q2 2019$372,000
-49.5%
26,367
-34.2%
0.00%
-50.0%
Q1 2019$737,000
-15.1%
40,053
+20.6%
0.00%
-33.3%
Q4 2018$868,000
+39.8%
33,208
+22.6%
0.00%
+50.0%
Q3 2018$621,000
+10250.0%
27,090
+8695.5%
0.00%
Q2 2018$6,000
+100.0%
308
+92.5%
0.00%
Q1 2018$3,000
-93.9%
160
-95.0%
0.00%
Q4 2017$49,000
+880.0%
3,224
+974.7%
0.00%
Q3 2017$5,0000.0%3000.0%0.00%
Q2 2017$5,000
+25.0%
3000.0%0.00%
Q1 2017$4,0003000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders